Benefits

Dashboard

See Price & Plans

Not registered yet? Get a free account.

Eugia Pharma Specialities Limited
Location
People
Financials
- Financial Highlights
- Balance Sheet
- Profit & Loss
- Ratios
Charges
Network
T. Score
Registered Details

EUGIA PHARMA SPECIALITIES LIMITED

www.aurobindo.com

All Companies ›

Telangana ›

Manufacturing of Chemical Products ›

EUGIA PHARMA SPECIALITIES LIMITED

Active

Updated: 08 Aug 2025

Eugia Pharma Specialities Limited, is an unlisted public company incorporated on 17 April, 2013. It is classified as a public limited company and is located in , Telangana. It's authorized share capital is INR 800.00 cr and the total paid-up capital is INR 621.01 cr.

Eugia Pharma Specialities Limited's operating revenue range is Over INR 500 cr for the financial year ending on 31 March, 2024. It's EBITDA has increased by 113.19% over the previous year. At the same time, it's book networth has increased by 68.12%.

Subscription Plans

Industry and products

Manufacturing of Pharmaceuticals

Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

Company size

Auth Capital

₹ 800.0 Cr

Paidup Capital

₹ 621.0 Cr

Revenue

₹ 3000-3250 cr

Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Total Revenue

55.49%

₹ 3,194.2

EBITDA

113.19%

₹ 1,405.0

Net Profit

198.9%

₹ 800.4

Networth

68.12%

₹ 1,973.3

Borrowings

-16.39%

₹ 1,669.8

Assets

7.53%

₹ 4,345.5

Gross Margin

6.95

72.7 %

Operating Margin

11.87

44.6 %

Net Profit Margin

12.02

25.1 %

Return on Equity

17.75

40.6 %

ROCE

31.12

47.1 %

Debt to Equity

-0.85

0.8

Sales

Mar 2024

Net worth

Mar 2024

Buy Report or Plans

Dashboards

Popular Plan

Company dashboard

₹ 449
- Five year financials and ratios
- Risk analysis
- Interactive charts

Buy credits

View subscriptions

MCA Fillings

All financials

₹ 349
- All financials
- All annual returns
- MoA and AoA
1 Year

₹ 249
- Latest financials
- Latest annual return
- MoA and AoA

PDF Reports

Financial report

₹ 799
- Five year financials and ratios
- Shareholding and group structure
Financial+Litigation report

₹ 1299
- Everything in financial report
- Litigation report on the company
Due diligence report

₹ 2999
- Everything in financial+litigation report
- Peers and financials

* GST not included

** Reports & MCA filings will be based on the latest available financials.

Locations

India (7)

State	Type	Address

Locations on Map

People

Designation	Name	DIN/PAN	Tenure
Director	Ragunathan Kannan	00523576	4 years
Director	Sundari Raviprasad Pisupati	01908852	4 years
Director	Yugandhar Puvvala	09379957	4 years
Director	Madan Mohan Reddy Mettu Shareholder	01284266	12 years
Director	Santhanam Subramanian	03516515	4 years
Director	Veerayya Chowdary Kosaraju	08485334	4 years

Financial Highlights

** All numbers in INR crores

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	142.1	402.3	1,702.2	2,014.4	3,150.9
Operating profit	41.2	119.6	575.4	659.0	1,405.0
Net profit	-24.6	0.2	367.1	267.8	800.4
Gross margin	83.3	60.5	64.5	65.7	72.7
Operating margin	29.0	29.7	33.8	32.7	44.6
Net margin	-17.1	0.0	20.8	13.0	25.1
Networth	470.6	919.1	905.7	1,173.8	1,973.3
Borrowings	477.5	311.5	890.0	1,997.0	1,669.8
Assets	1,079.5	1,557.6	3,189.4	4,041.1	4,345.5
Debt to equity	1.0	0.3	1.0	1.7	0.8
Current ratio	0.8	1.3	1.1	2.3	1.6
ROE	-5.2	0.0	40.5	22.8	40.6
Days payable	547.0	262.0	186.0	180.0	194.0
WC days	-108.0	94.0	39.0	181.0	93.0

Margins

Gross margin

Operating margin

Net margin

Balance Sheet

Standalone

Consolidated

₹

** All numbers in INR crores

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	477.1	621.0	621.0	621.0	621.0
Reserves	-6.5	298.1	284.7	552.8	1,352.3
Borrowings +	477.5	311.5	890.0	1,997.0	1,669.8
Long term borrowings	432.0	267.9	890.0	1,997.0	986.3
Short term borrowings	45.5	43.6	-	-	683.5
Trade payables +	35.6	114.0	307.6	340.8	457.0
Days payable	547.0	262.0	186.0	180.0	194.0
Other liabilities +	131.3	327.1	1,393.7	870.3	702.4
Other non-current liabilities	0.6	3.1	37.2	125.7	151.8
Other current liabilities	95.1	210.0	1,048.9	403.8	93.6
Total liabilities	1,079.5	1,557.6	3,189.4	4,041.1	4,345.5
Fixed Assets +	876.4	990.3	1,544.1	1,808.8	1,700.5
Tangible assets	441.3	548.3	929.7	961.6	1,052.9
CWIP	417.2	376.8	524.0	481.9	363.0
Intangible assets	17.9	65.2	90.4	365.3	284.6
LT loans and advances	-	-	-	-	-
Other non-current assets	68.9	96.4	106.7	490.3	611.5
Current assets +	134.2	471.0	1,538.7	1,742.1	2,033.5
Inventories	70.1	225.9	497.9	578.2	713.5
Trade receivables	8.4	162.4	411.1	675.3	799.3
Cash and cash equivalents	24.3	0.2	112.8	120.6	47.3
ST loans and advances	-	-	2.1	1.7	2.0
Other current assets	31.5	82.5	514.8	366.3	471.4
Total assets	1,079.5	1,557.6	3,189.4	4,041.1	4,345.5

Percentage of assets	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	44.2	39.87	19.47	15.37	14.29
Reserves	-0.6	19.14	8.93	13.68	31.12
Borrowings +	44.24	20.0	27.9	49.42	38.43
Long term borrowings	40.02	17.2	27.9	49.42	22.7
Short term borrowings	4.21	2.8	0.0	0.0	15.73
Trade payables	3.3	7.32	9.64	8.43	10.52
Other liabilities +	12.16	21.0	43.7	21.54	16.16
Other non-current liabilities	0.06	0.2	1.17	3.11	3.49
Other current liabilities	8.81	13.48	32.89	9.99	2.15
Total liabilities
Fixed Assets +	81.18	63.57	48.41	44.76	39.13
Tangible assets	40.88	35.2	29.15	23.8	24.23
CWIP	38.65	24.19	16.43	11.92	8.35
Intangible assets	1.65	4.19	2.83	9.04	6.55
LT loans and advances	0.0	0.0	0.0	0.0	0.0
Other non-current assets	6.38	6.19	3.34	12.13	14.07
Current assets +	12.44	30.24	48.24	43.11	46.8
Inventories	6.49	14.5	15.61	14.31	16.42
Trade receivables	0.78	10.43	12.89	16.71	18.39
Cash and cash equivalents	2.25	0.02	3.54	2.98	1.09
ST loans and advances	0.0	0.0	0.07	0.04	0.05
Other current assets	2.92	5.29	16.14	9.06	10.85
Total assets

	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	621.0	621.0	621.0	621.0
Reserves	298.1	285.7	1,207.4	1,840.3
Borrowings +	307.7	990.5	2,366.0	2,149.9
Long term borrowings	264.1	989.5	2,366.0	1,466.4
Short term borrowings	43.6	1.0	-	683.5
Trade payables +	220.0	353.3	693.1	778.2
Days payable	294.0	175.0	237.0	198.0
Other liabilities +	1,795.9	1,807.8	1,170.4	1,359.7
Other non-current liabilities	11.3	45.7	236.5	165.8
Other current liabilities	1,564.6	1,408.8	240.7	415.7
Total liabilities	3,022.7	3,704.9	5,364.8	5,970.9
Fixed Assets +	1,583.2	1,854.4	3,045.3	2,548.8
Tangible assets	1,098.4	1,132.2	1,215.3	1,613.6
CWIP	419.6	631.8	1,385.1	553.9
Intangible assets	65.2	90.4	444.9	381.3
LT loans and advances	0.4	0.1	0.1	0.1
Other non-current assets	104.9	48.6	285.6	715.7
Current assets +	1,334.2	1,801.8	2,033.8	2,706.2
Inventories	558.5	563.6	874.9	1,110.0
Trade receivables	659.9	526.5	439.0	838.9
Cash and cash equivalents	0.3	190.7	231.1	196.0
ST loans and advances	2.2	2.4	2.0	2.3
Other current assets	113.2	518.6	486.8	559.0
Total assets	3,022.7	3,704.9	5,364.8	5,970.9

Percentage of assets	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	20.54	16.76	11.58	10.4
Reserves	9.86	7.71	22.51	30.82
Borrowings +	10.18	26.73	44.1	36.01
Long term borrowings	8.74	26.71	44.1	24.56
Short term borrowings	1.44	0.03	0.0	11.45
Trade payables	7.28	9.54	12.92	13.03
Other liabilities +	59.41	48.79	21.82	22.77
Other non-current liabilities	0.37	1.23	4.41	2.78
Other current liabilities	51.76	38.03	4.49	6.96
Total liabilities
Fixed Assets +	52.38	50.05	56.76	42.69
Tangible assets	36.34	30.56	22.65	27.02
CWIP	13.88	17.05	25.82	9.28
Intangible assets	2.16	2.44	8.29	6.39
LT loans and advances	0.01	0.0	0.0	0.0
Other non-current assets	3.47	1.31	5.32	11.99
Current assets +	44.14	48.63	37.91	45.32
Inventories	18.48	15.21	16.31	18.59
Trade receivables	21.83	14.21	8.18	14.05
Cash and cash equivalents	0.01	5.15	4.31	3.28
ST loans and advances	0.07	0.07	0.04	0.04
Other current assets	3.75	14.0	9.07	9.36
Total assets

Total assets

Profit & Loss

Standalone

Consolidated

₹

** All numbers in INR crores

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales +	142.1	402.3	1,702.2	2,014.4	3,150.9
Sales growth %	None	183.02	323.14	18.34	56.42
Expenses +	176.2	404.8	1,301.3	1,695.7	2,116.0
Cost of goods	23.8	159.0	605.2	690.9	861.9
Employee cost	35.7	55.7	182.5	211.0	262.7
Other costs	41.4	68.0	339.1	453.5	621.4
Operating profit +	41.2	119.6	575.4	659.0	1,405.0
Operating margin %	29.0	29.7	33.8	32.7	44.6
Other income	1.2	3.6	64.9	40.0	43.3
Interest	41.5	39.5	40.5	129.1	141.8
Depreciation	33.7	82.7	134.0	211.3	228.3
Exceptional items	-	-	-	-	-
Profit before tax	-32.8	1.1	465.8	358.6	1,078.3
Tax	-8.3	0.9	98.7	90.8	277.8
Profit - disc. ops	-	-	-	-	-
Net profit	-24.6	0.2	367.1	267.8	800.4
Net margin %	-17.1	0.0	20.8	13.0	25.1

Precentage of total income	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	99.15	99.11	96.33	98.06	98.64
Expenses +	122.89	99.74	73.64	82.54	66.24
Cost of goods	16.58	39.18	34.25	33.63	26.98
Employee cost	24.92	13.71	10.33	10.27	8.22
Other costs	28.9	16.75	19.19	22.07	19.45
Operating profit	28.75	29.47	32.56	32.08	43.99
Other income	0.85	0.89	3.67	1.94	1.36
Interest	28.98	9.73	2.29	6.28	4.44
Depreciation	23.51	20.37	7.58	10.29	7.15
Exceptional items	0.0	0.0	0.0	0.0	0.0
Profit before tax	-22.89	0.26	26.36	17.46	33.76
Tax	-5.76	0.23	5.58	4.42	8.7
Profit - disc. ops	0.0	0.0	0.0	0.0	0.0
Net profit	-17.13	0.04	20.77	13.04	25.06

	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales +	805.8	1,944.9	2,811.4	4,293.5
Sales growth %	None	141.36	44.55	52.72
Expenses +	644.2	1,552.2	2,433.6	3,129.7
Cost of goods	273.1	737.2	1,069.3	1,432.0
Employee cost	97.5	220.9	319.0	398.5
Other costs	156.8	397.6	673.3	889.6
Operating profit +	278.3	589.3	749.8	1,573.4
Operating margin %	34.5	30.3	26.7	36.6
Other income	3.6	68.4	17.1	33.5
Interest	39.5	40.5	129.4	145.0
Depreciation	77.3	156.1	242.6	264.5
Exceptional items	-	-	-	-281.7
Profit before tax	165.2	461.1	394.9	915.7
Tax	0.9	99.8	99.2	292.2
Profit - disc. ops	-	-	-	-
Net profit	164.3	361.4	295.7	623.5
Net margin %	20.3	17.9	10.4	14.4

Precentage of total income	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	99.55	96.6	99.39	99.23
Expenses +	79.59	77.1	86.04	72.33
Cost of goods	33.74	36.61	37.81	33.09
Employee cost	12.05	10.97	11.28	9.21
Other costs	19.38	19.75	23.8	20.56
Operating profit	34.39	29.27	26.51	36.36
Other income	0.45	3.4	0.61	0.77
Interest	4.88	2.01	4.58	3.35
Depreciation	9.55	7.75	8.58	6.11
Exceptional items	0.0	0.0	0.0	-6.51
Profit before tax	20.41	22.9	13.96	21.16
Tax	0.11	4.95	3.51	6.75
Profit - disc. ops	0.0	0.0	0.0	0.0
Net profit	20.3	17.95	10.45	14.41

Revenue from operations

Ratios

Standalone

Consolidated

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Solvency +
Total Debt/Equity	1.0	0.3	1.0	1.7	0.8
Net Debt/Equity	1.0	0.3	0.9	1.6	0.8
Total Debt/Assets	0.4	0.2	0.3	0.5	0.4
Total Assets/Equity	2.3	1.7	3.5	3.4	2.2
Liquidity +
Current Ratio	0.8	1.3	1.1	2.3	1.6
Quick Ratio	0.4	0.7	0.8	1.6	1.1
Interest Coverage	1.0	3.0	14.2	5.1	9.9
Performance
Gross Margin	83.3	60.5	64.5	65.7	72.7
Operating Margin	29.0	29.7	33.8	32.7	44.6
Net Margin	-17.1	0.0	20.8	13.0	25.1
Return +
Return on Equity	-5.2	0.0	40.5	22.8	40.6
Pre-tax ROCE	0.9	3.4	25.6	15.9	47.1
Return on Assets	-2.3	0.0	11.5	6.6	18.4
Pre-tax ROIC	0.8	3.0	26.2	14.7	32.7
Efficiency +
Days Payable	547.0	262.0	186.0	180.0	194.0
Days Inventory	1,077.0	518.0	300.0	305.0	302.0
Days Receivable	22.0	147.0	88.0	122.0	93.0
Fixed Asset Turnover	0.2	0.4	1.1	1.1	1.9
Total Asset Turnover	0.1	0.3	0.5	0.5	0.7
Working Capital
Cash Conversion Cycle	552.0	403.0	202.0	247.0	201.0
Working Capital Days	-108.0	94.0	39.0	181.0	93.0

	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Solvency +
Total Debt/Equity	0.3	1.1	1.3	0.9
Net Debt/Equity	0.3	0.9	1.2	0.8
Total Debt/Assets	0.1	0.3	0.4	0.4
Total Assets/Equity	3.3	4.1	2.9	2.4
Liquidity +
Current Ratio	0.7	1.0	2.2	1.4
Quick Ratio	0.4	0.7	1.2	0.8
Interest Coverage	7.0	14.5	5.8	10.8
Performance
Gross Margin	66.1	62.1	62.0	66.7
Operating Margin	34.5	30.3	26.7	36.6
Net Margin	20.3	17.9	10.4	14.4
Return +
Return on Equity	17.9	39.9	16.2	25.3
Pre-tax ROCE	18.5	22.9	12.2	38.8
Return on Assets	5.4	9.8	5.5	10.4
Pre-tax ROIC	16.4	25.4	12.8	29.6
Efficiency +
Days Payable	294.0	175.0	237.0	198.0
Days Inventory	746.0	279.0	299.0	283.0
Days Receivable	299.0	99.0	57.0	71.0
Fixed Asset Turnover	0.5	1.1	0.9	1.7
Total Asset Turnover	0.3	0.5	0.5	0.7
Working Capital
Cash Conversion Cycle	751.0	203.0	119.0	156.0
Working Capital Days	-224.0	7.0	143.0	70.0

Ratios

Current ratio

Debt/equity ratio

Charges on assets

As per information available, the company has no registered charges.

Company Network

Companies connected through Directors

Name	Status	Paid up Capital	Common Directors	Address
TRUST AMC TRUSTEE PRIVATE LIMITED	Active	50.0 L	1	Maharashtra
NU GENES AGRI BUSINESS PRIVATE LIMITED	Active	1.8 L	1	Telangana
SATHGURU MANAGEMENT CONSULTANTS PVT LTD	Active	30.0 L	1	Telangana
SATHGURU SOFTWARE PRODUCTS PRIVATE LIMITED	Active	6.8 Cr	1	Telangana
PREMIER ENERGIES LIMITED	Active	45.1 Cr	1	Telangana
PRAVESHA INDUSTRIES PRIVATE LIMITED	Active	14.8 Cr	1
FERNANDEZ FOUNDATION	Active	24.0 L	1
OREMSI PLASTICS PRIVATE LIMITED	Strike Off	1.3 L	1	Telangana
CUREPRO PARENTERALS LIMITED	Amalgamated	13.3 Cr	1	Telangana
AURONEXT PHARMA PRIVATE LIMITED	Amalgamated	125.0 Cr	1	Telangana
THERANYM BIOLOGICS PRIVATE LIMITED	Active	10.0 L	2	Telangana
AUROZEST PRIVATE LIMITED	Active	10.0 L	1	Telangana
AURO VACCINES PRIVATE LIMITED	Active	10.0 L	1	Telangana
CREST EXCIPIENTS LLP	Strike Off	1.3 L	1	Telangana
EUGIA STERILES PRIVATE LIMITED	Active	44.2 Cr	2	Telangana
CURATEQ BIOLOGICS PRIVATE LIMITED	Active	100.0 Cr	1	Telangana
EUGIA SEZ PRIVATE LIMITED	Active	4.0 Cr	2	Telangana
AUROBINDO PHARMA LTD	Active	58.1 Cr	1	Telangana
RAINBOW SPECIALITY HOSPITALS PRIVATE LIMITED	Active	18.0 Cr	1	Telangana
RAINBOW CHILDREN'S MEDICARE LIMITED	Active	101.6 Cr	1	Telangana
QULE PHARMA PRIVATE LIMITED	Active	10.0 L	1	Andhra Pradesh
AUROACTIVE PHARMA PRIVATE LIMITED	Active	100.0 Cr	1	Telangana
TERGENE BIOTECH LIMITED	Active	45.0 Cr	1	Telangana
LYFIUS PHARMA PRIVATE LIMITED	Active	10.0 L	1	Andhra Pradesh
APITORIA PHARMA PRIVATE LIMITED	Active	99.0 Cr	1	Telangana
GENOME FOUNDATION	Active	81.5 L	1	Telangana
GMR VARALAKSHMI FOUNDATION	Active	0.0	1	Andhra Pradesh
CCL PRODUCTS (INDIA) LIMITED	Active	26.7 Cr	1	Andhra Pradesh
YASHODA HEALTHCARE SERVICES LIMITED	Active	184.0 Cr	1
MY HOME INDUSTRIES PRIVATE LIMITED	Active	51.0 Cr	1	Telangana
RELIANCE INDUSTRIES LIMITED	Active	13,532.5 Cr	1	Maharashtra
ANANT RAJ LIMITED	Active	68.7 Cr	1	Haryana
NUZIVEEDU SEEDS LIMITED	Active	86.3 Cr	1	Telangana
DIVI'S LABORATORIES LIMITED	Active	53.0 Cr	1	Telangana
TATA MOTORS LIMITED	Active	736.3 Cr	1	Maharashtra
RELIANCE JIO INFOCOMM LIMITED	Active	154,125.0 Cr	1	Gujarat

Subsidiary Companies

Name	State / Country	Incorporation Year	Paidup Capital
EUGIA SEZ PRIVATE LIMITED	Telangana	2021	₹ 4.0 Cr
EUGIA INJECTABLE INC.,USA	United States	-	-
EUGIA STERILES PRIVATE LIMITED	Telangana	2020	₹ 44.2 Cr
Eugia Pharma B.V	Netherlands	-	-
Eugia pharma (malta) limited	Malta	-	-
Eugia (uk) limited	United Kingdom	-	-
Eugia Pharma Inc Canada	Canada	-	-
Eugia Pharma (Austalia) PTY Limited	Australia	-	-
Eugia pharma industria farmaceutica limitada	Brazil	-	-
Eugia Inc	United States	-	-
Eugia pharma colombia SAS	Colombia	-	-

Tofler Score

Very Good

Poor

Fair

Good

Very Good

Excellent

Risk

Severe Risk

No risks identified

Moderate Risk

LOW CASH BALANCE
CASH DETERIORATING

Low Risk

HIGH INVENTORY

About Tofler Score

Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

CIN

U24297TG2013PLC087048

PAN

AADCE3429K

Incorporation

2013, 12.4 years

Company Email

cs@eugiapharma.com

Paid up Capital

₹ 621.0 Cr

Authorised Capital

₹ 800.0 Cr

AGM

Jul 2024

Type

Public

Others

FAQ - EUGIA PHARMA SPECIALITIES LIMITED

What is the incorporation date of EUGIA PHARMA SPECIALITIES LIMITED?

The incorporation date of EUGIA PHARMA SPECIALITIES LIMITED is 17 April, 2013

What is the authorized share capital of EUGIA PHARMA SPECIALITIES LIMITED?

The authorized share capital of EUGIA PHARMA SPECIALITIES LIMITED is INR ₹ 800.0 Cr.

What is the paid-up capital of EUGIA PHARMA SPECIALITIES LIMITED?

The paid-up capital of EUGIA PHARMA SPECIALITIES LIMITED is INR ₹ 621.0 Cr.

What is the registered address of EUGIA PHARMA SPECIALITIES LIMITED?

The registered address of EUGIA PHARMA SPECIALITIES LIMITED is Plot No.2, Maitrivihar, Hyderabad, Ameerpet, Telangana, India, 500038 - 500038

What is the CIN number of EUGIA PHARMA SPECIALITIES LIMITED?

The CIN number of EUGIA PHARMA SPECIALITIES LIMITED is U24297TG2013PLC087048.

Smart Suggestions

Uttar Pradesh
Haryana
Jammu & Kashmir
Punjab
Goa
Madhya Pradesh
Kerala
Gujarat
Andhra Pradesh
Telangana
Blog Categories
Top Blog post
Financial Resources

Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More

EUGIA PHARMA SPECIALITIES LIMITED

Leave site?

Buy Dashboard using Credits

Just a Quick Check!

Buy Report or Plans

Dashboards

Company dashboard

Buy credits

View subscriptions

MCA Fillings

All financials

1 Year

PDF Reports

Financial report

Financial+Litigation report

Due diligence report

Choose number of credits to buy

₹ 449 + GST

Locations

Locations on Map

Filter (4)

Select Tags

Choose Location

People

Financial Highlights

Margins

Balance Sheet

Total assets

Profit & Loss

Revenue from operations

Ratios

Ratios

Charges on assets

Company Network